摘要
目的:观察生脉注射液联合西药治疗糖尿病并继发性肺结核的临床疗效。方法:60例患者随机分为对照组和治疗组各30例,对照组采用糖尿病综合治疗和HRZV强化抗痨治疗,治疗组在对照组治疗的基础上采用生脉注射液静脉注射治疗。结果:两组临床疗效、血糖及糖化血红蛋白变化情况、T淋巴细胞亚群变化情况、痰菌转阴情况、肺部病灶吸收情况等方面比较均具有显著性差异(P<0.05或P<0.01)。结论:生脉注射液联合西药治疗糖尿病并继发性肺结核疗效较佳。
Objective：To observe the clinical effects of Shengmai Injection and Western medicine on diabetes and the secondary pulmonary tuberculosis.Methods： 60 patients were randomly divided into the control group and treatment group,30 cases in each group.The control group was given a comprehensive diabetes treatment and HRZV strengthening anti-tuberculosis treatment,while the treatment group received intravenous injection of Shengmai Injection treatment.Results： There was a significant difference（P0.05 or P0.01） between two groups in the clinical effects,changes in blood glucose and glycated hemoglobin,changes of T lymphocyte subsets,negative changes of sputum,the absorption of lung lesion.Conclusion： Shengmai Injection combined with Western medicine has better clinical effects on diabetes and the secondary pulmonary tuberculosis.
出处
《河南中医》
2011年第11期1255-1257,共3页
Henan Traditional Chinese Medicine
关键词
糖尿病
肺结核
生脉注射液
中西医结合疗法
diabetes
tuberculosis
Shengmai Injection
Combine traditional Chinese and Western medicine
作者简介
陈五海（1975-），男，安徽黄山人，硕士学位，主治医师。
